Status:
COMPLETED
Clinical Study of the HeartLight X3 Endoscopic Ablation System With Excalibur Balloon
Lead Sponsor:
CardioFocus
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The objective of the study is to demonstrate the improved ablation and procedure times of the HeartLight X3 compared to the current HeartLight catheter in the treatment of atrial fibrillation.
Eligibility Criteria
Inclusion
- paroxysmal atrial fibrillation failure of at least one AAD others
Exclusion
- overall good health as established by multiple criteria
Key Trial Info
Start Date :
February 15 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 16 2020
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03470636
Start Date
February 15 2018
End Date
January 16 2020
Last Update
February 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nemocnice Na Homolce
Prague, Czechia